Additionally, in the U.S. alone, these specific medications could generate $70 billion in revenue. That analysis is according to Evan David Seigerman, an analyst at BMO Capital Markets.
As patients begin to understand the efficacy of the medications, particularly as it relates to weight-loss, the demand will begin to rise, according to Fortune.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
